InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
43%
T+90 mean return
+8.5%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by ANDERSON ELIZABETH M, Director. Director active across 5 companies, notably INSMED Inc. Cumulatively, 21 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €1.7m. History available since 25 May 2021. The latest transaction was disclosed on 14 November 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations21 total
3,305 sharesCommon StockSEC:0001758247-26-000002:0
3,305 sharesCommon StockSEC:0001758247-26-000002
10,000 shares@ US$195.87100.0% of flowCommon StockSEC:0001758247-25-000004:0
6,650 shares0Common StockSEC:0001048477-25-000062:0
5,058 sharesCommon StockSEC:0001628280-25-026565:0
4,248 shares0Common StockSEC:0001610717-24-000379:0
4,800 shares0Common StockSEC:0001610717-24-000356:0
4,720 shares0Common StockSEC:0001048477-24-000092:0
13,162 sharesCommon StockSEC:0001628280-24-023557:0
5,200 shares0Common StockSEC:0001610717-23-000133:0
4,190 shares0Common StockSEC:0001209191-23-031965:0
13,192 sharesCommon StockSEC:0001628280-23-018198:0
5,200 shares0Common StockSEC:0001567619-22-013109:0
4,980 shares0Common StockSEC:0001567619-22-011786:0
14,645 sharesCommon StockSEC:0001140361-22-019183:0
3,617 shares0Common StockSEC:0001567619-21-012590
3,617 shares0Common StockSEC:0001567619-21-012590:0
5,120 shares0Common StockSEC:0001567619-21-011257:0
5,120 shares0Common StockSEC:0001567619-21-011257
7,558 sharesCommon StockSEC:0001140361-21-017419
7,558 sharesCommon StockSEC:0001140361-21-017419:0
21 of 21 declarations
About ANDERSON ELIZABETH M
Elizabeth M. Anderson serves as a Board Member at Insmend Inc and BioMarin Pharmaceutical Inc. She has a strong background in the pharmaceutical and biopharmaceutical sectors. As a board member, Elizabeth plays a key role in the strategic direction of these companies, ensuring they adhere to governance and ethical standards. Her expertise contributes to strategic decision-making to foster growth and innovation.
